Dr. Tina Moore — A naturopathic physician and chiropractor with a focus on metabolic and longevity medicine. She advocates microdosing GLP-1 drugs like Ozempic for healing rather than rapid weight loss, and authored the book 'Pain Free and Strong.'
The gist
Dr. Tina Moore makes the case that GLP-1 agonists like Ozempic (semaglutide) are routinely overdosed for weight loss, causing avoidable side effects, when tiny 'microdoses' could instead deliver anti-inflammatory, regenerative, and neuroprotective benefits. She explains the science of GLP-1 as a naturally occurring peptide and points to studies showing cardiovascular, cancer-risk, fertility, mood, and addiction benefits often independent of weight loss. She frames metabolic dysfunction, driven by an adulterated food supply, toxins, and modern lifestyle, as the root cause of widespread chronic disease and a looming fertility crisis. Throughout she stresses that the drug only works alongside non-negotiable lifestyle pillars: strength training, protein, sunlight, sleep, community, and mindset. She shares personal and family case studies, including reversing her own debilitating psoriatic arthritis and her mother's Crohn's-related decline.
Big reveals
- Says by the end of 2021, crippled by chronic pain, she thought 'if this doesn't get better, I think I'm going to kill myself.'
- Reveals she missed her own mother's Crohn's disease for years and still carries guilt over it.
- Describes microdosing her own GLP-1 and feeling brain fog and anxiety lift within days.
- Cites the Novo Nordisk-funded SELECT trial showing a 20% reduction in major cardiovascular events.
- Notes SELECT data re-analysis found cardiovascular benefits occurred even in people who didn't lose weight.
- Demonstrates that standard dosing 10x's the dose over 16 weeks, which she calls unnecessary and high-risk.
- Claims by the mid-2040s sperm rates are projected to hit zero and frames metabolic dysfunction as the driver.
- Argues the Women's Health Initiative wrongly scared a generation of women off hormone therapy.
Things worth remembering
- GLP-1 receptors exist throughout the body and the drug is described as inducing neuroplasticity and neuron regeneration.
- She cites data on pancreatic beta-cell regeneration in type 1 diabetics if treated early enough.
- A chronic kidney disease (FLOW) trial was reportedly stopped early because the drug was so effective.
- A 2024 study (Lindsey Wang) found diabetics on Ozempic were 50% less likely to develop bowel cancer than those on insulin.
- 2018 US data showed only 6.8% of US adults are metabolically healthy.
- In rat studies, semaglutide stopped rats seeking 'pleasure food' while they kept eating standard chow.
- A 186-person type 2 diabetes study found the strength-training-only group lost the most fat and most improved insulin resistance.
- Sauna-induced heat shock proteins are linked to roughly a 40% reduction in pneumonia risk.
- GLP-1 is produced in regions of the brain itself, not only the gut, with receptors all over the brain.
- As a child her ADHD ('hyperkinetic') prescription was a dog, constant physical activity, and avoiding 'white foods.'
Recommended in this episode
Books, products and media the guest or host genuinely endorsed here — with the buy link.
Affiliate link — we may earn a commission at no extra cost to you.
Pain Free and Strong
Dr. Tina Moore
“these sound very similar to your six pillars for a pain-free life which you write about in your book Pain Free and Strong” — Steven Bartlett 01:42:41Find it on Amazon